Old Web
English
Sign In
Acemap
>
authorDetail
>
Jan A. Burger
Jan A. Burger
University of Texas Health Science Center at Houston
Medicine
Internal medicine
Oncology
Ibrutinib
Chronic lymphocytic leukemia
3
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia.
2020
Leukemia
Mariela Sivina
Lianchun Xiao
Ekaterina Kim
Alicia Vaca
Shih-Shih Chen
Michael J. Keating
Alessandra Ferrajoli
Zeev Estrov
Nitin Jain
William G. Wierda
Xuelin Huang
Nicholas Chiorazzi
Jan A. Burger
Show All
Source
Cite
Save
Citations (1)
Achieving Complete Remission in CLL Patients Treated with Ibrutinib: Clinical Significance and Predictive Factors
2020
Blood
Paolo Strati
Ellen J Schlette
Luisa M. Solis Soto
Daniela E. Duenas
Mariela Sivina
Ekaterina Kim
Michael J. Keating
William G. Wierda
Alessandra Ferrajoli
Hagop M. Kantarjian
Zeev Estrov
Nitin Jain
Philip A. Thompson
Ignacio I. Wistuba
Jan A. Burger
Show All
Source
Cite
Save
Citations (6)
Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States
2019
Cancer Medicine
Iman Abou Dalle
Hagop M. Kantarjian
Jan A. Burger
Zeev Estrov
Maro Ohanian
Srdan Verstovsek
Farhad Ravandi
Gautam Borthakur
Guillermo Garcia-Manero
Elias Jabbour
Jorge E. Cortes
Show All
Source
Cite
Save
Citations (9)
1